The stock is in a volatile recovery phase from deep lows, with a 1-year price change of 9.05% masking a tumultuous journey that includes a 6-month decline of -40.99%. Currently trading at $27.24, the price sits at approximately 77% of its 52-week range ($16.78 to $52.15), indicating it has recovered significantly from its lows but remains well off its highs, suggesting room for further recovery if the turnaround narrative holds but facing substantial overhead resistance. Recent momentum has been exceptionally strong, with a 3-month surge of 40.20% and a 1-month gain of 1.30%, sharply diverging from the longer-term downtrend; this powerful short-term rally, highlighted by a spike from below $20 in late March to over $32 in early June, signals a potential trend reversal driven by positive fundamental catalysts, though the recent pullback from the June highs suggests consolidation. Key technical support is the 52-week low of $16.78, a level that represents the recent capitulation point, while major resistance is the 52-week high of $52.15. A sustained breakout above the recent June high near $32 could signal the next leg of the recovery, while a breakdown below the $20 support level would threaten the nascent uptrend. The stock's beta of 2.046 indicates it is over 100% more volatile than the broader market (SPY), which is critical for risk management as this high volatility amplifies both upside moves and potential drawdowns, as evidenced by the -65.37% max drawdown.

Revenue growth has been modest but positive, with Q4 2025 revenue of $503.1 million representing a 10.1% year-over-year increase; however, examining the quarterly trend from the income statement shows revenue has been relatively flat sequentially ($435.0M in Q1, $440.9M in Q2, $470.6M in Q3, $503.1M in Q4), suggesting stabilization rather than robust acceleration, though the recent guidance raise points to potential re-acceleration. The company remains deeply unprofitable, with a Q4 2025 net income of -$89.96 million and a net margin of -17.9%, but there is a clear improving trajectory as losses have narrowed significantly from -$291.1 million in Q1 2024; gross margin was 61.2% in Q4, down from the 74.1% trailing gross margin, indicating potential product mix shifts or cost pressures that require monitoring against the industry-typical high software margins. The balance sheet shows a strong liquidity position with a current ratio of 1.84 and a moderate debt-to-equity ratio of 0.74, indicating manageable financial leverage. Crucially, the company is generating substantial free cash flow, with TTM free cash flow of $403.9 million, providing an internal funding source for its turnaround efforts and reducing reliance on external capital; this positive cash generation, coupled with an ROE of -12.4%, underscores that while the equity base is being eroded by losses, the operational cash flow story is a key pillar of the bull case.